Pyxis Oncology, Inc.
NASDAQ:PYXS
1.07 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 19.473 | 9.664 | 179.293 | 274.735 | 8.08 | 19.69 |
| Short Term Investments
| 107.458 | 109.634 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 126.931 | 119.298 | 179.293 | 274.735 | 8.08 | 19.69 |
| Net Receivables
| 0 | 0.021 | 0.598 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0.874 | 0 | 0 | 0 |
| Other Current Assets
| 4.748 | 5.285 | 6.721 | 3.938 | 0.023 | 0.011 |
| Total Current Assets
| 132.44 | 124.604 | 186.612 | 278.673 | 8.103 | 19.701 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 22.141 | 24.814 | 24.767 | 1.239 | 1.939 | 0.076 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 2.6 | 24.308 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 2.6 | 24.308 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0 | 0.109 | 0.109 | 0.03 |
| Total Non-Current Assets
| 24.741 | 49.122 | 24.767 | 1.348 | 2.048 | 0.106 |
| Total Assets
| 157.181 | 173.726 | 211.379 | 280.021 | 10.151 | 19.807 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.859 | 3.896 | 7.097 | 11.951 | 1.077 | 0.491 |
| Short Term Debt
| 0 | 1.232 | 0 | 0.33 | 0.615 | 0.009 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0.064 | 0.109 |
| Deferred Revenue
| 0 | 7.66 | 0 | 6.326 | 1.945 | 0.224 |
| Other Current Liabilities
| 12.821 | 12.971 | 24.537 | 6.427 | 1.933 | 0.124 |
| Total Current Liabilities
| 17.68 | 25.759 | 31.634 | 18.708 | 3.689 | 0.733 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 20.099 | 18.921 | 0 | 0.165 | 0.006 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 2.164 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 21.942 | 21.942 |
| Total Non-Current Liabilities
| 18.75 | 22.263 | 18.921 | 0 | 22.107 | 21.948 |
| Total Liabilities
| 36.43 | 48.022 | 50.555 | 18.708 | 25.796 | 22.681 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 280.021 | 21.942 | 21.942 |
| Common Stock
| 0.06 | 0.045 | 0.034 | 0.032 | 0.001 | 0.001 |
| Retained Earnings
| -363.556 | -286.225 | -212.435 | -91.718 | -15.743 | -2.915 |
| Accumulated Other Comprehensive Income/Loss
| 0.17 | 0.063 | 0 | -280.021 | -21.942 | -21.942 |
| Other Total Stockholders Equity
| 484.077 | 411.821 | 373.225 | 72.978 | 43.988 | 0.04 |
| Total Shareholders Equity
| 120.751 | 125.704 | 160.824 | 261.313 | -15.645 | -2.874 |
| Total Equity
| 120.751 | 125.704 | 160.824 | 261.313 | -15.645 | -2.874 |
| Total Liabilities & Shareholders Equity
| 157.181 | 173.726 | 211.379 | 280.021 | 10.151 | 19.807 |